CURALEAF HOLDINGS, INC.

CURLF ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Jun 2025 Mar 2025 Dec 2024 Dec 2023 Dec 2022
Revenue $340.1M $310.6M
Cost of Revenue $170.2M $157.5M
Gross Profit $169.9M $153.1M
Gross Margin 50.0% 49.3%
Operating Expenses
Research & Development
SG&A Expense $131.7M $111.4M
Operating Income $4.2M $6.2M
Operating Margin 1.2% 2.0%
Interest Expense $13.7M
Pretax Income $-26.3M $-16.3M
Income Tax Expense $-38.8M $31.8M
Net Income $12.5M $69.8M $-53.2M $-61.1M
Net Margin 3.7% -17.1%
EPS (Basic) $0.05 $-0.26
EPS (Diluted) $0.05 $-0.26
Shares Outstanding (Basic) 263.1M 257.5M 252.4M 750.1M 733.7M 717.5M
Shares Outstanding (Diluted) 270.7M 257.5M 252.4M 750.1M 733.7M 717.5M
Dividends Per Share
← Newer Page 1 of 2 Older →